nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.0899	0.0899	CbGpPWpGaD
Neostigmine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.0802	0.0802	CbGpPWpGaD
Neostigmine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.0764	0.0764	CbGpPWpGaD
Neostigmine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.0759	0.0759	CbGpPWpGaD
Neostigmine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.0682	0.0682	CbGpPWpGaD
Neostigmine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.0677	0.0677	CbGpPWpGaD
Neostigmine—ACHE—Biogenic Amine Synthesis—COMT—attention deficit hyperactivity disorder	0.0462	0.0462	CbGpPWpGaD
Neostigmine—ACHE—Biogenic Amine Synthesis—MAOA—attention deficit hyperactivity disorder	0.0459	0.0459	CbGpPWpGaD
Neostigmine—ACHE—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.0416	0.0416	CbGpPWpGaD
Neostigmine—ACHE—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.0409	0.0409	CbGpPWpGaD
Neostigmine—ACHE—Monoamine Transport—SLC6A4—attention deficit hyperactivity disorder	0.0333	0.0333	CbGpPWpGaD
Neostigmine—ACHE—Monoamine Transport—SLC6A3—attention deficit hyperactivity disorder	0.0296	0.0296	CbGpPWpGaD
Neostigmine—ACHE—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0271	0.0271	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.0188	0.0188	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.0167	0.0167	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0144	0.0144	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0128	0.0128	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.0096	0.0096	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00857	0.00857	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00826	0.00826	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00768	0.00768	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00737	0.00737	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00736	0.00736	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00685	0.00685	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00684	0.00684	CbGpPWpGaD
Neostigmine—ACHE—ATF-2 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00663	0.00663	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00656	0.00656	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00633	0.00633	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.0061	0.0061	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00588	0.00588	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00582	0.00582	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00578	0.00578	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00578	0.00578	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00564	0.00564	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00525	0.00525	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00524	0.00524	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00519	0.00519	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00515	0.00515	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00468	0.00468	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00446	0.00446	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00443	0.00443	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00398	0.00398	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00395	0.00395	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00353	0.00353	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00336	0.00336	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00268	0.00268	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00264	0.00264	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00259	0.00259	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00252	0.00252	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00239	0.00239	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00185	0.00185	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00185	0.00185	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00182	0.00182	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00169	0.00169	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00165	0.00165	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00165	0.00165	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00163	0.00163	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00151	0.00151	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00148	0.00148	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00141	0.00141	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00132	0.00132	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00126	0.00126	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00123	0.00123	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00117	0.00117	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00113	0.00113	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.00112	0.00112	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00111	0.00111	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00108	0.00108	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.001	0.001	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000994	0.000994	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000964	0.000964	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000807	0.000807	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000807	0.000807	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000793	0.000793	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000738	0.000738	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000645	0.000645	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000614	0.000614	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000489	0.000489	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000485	0.000485	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—EP300—attention deficit hyperactivity disorder	0.000481	0.000481	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—EP300—attention deficit hyperactivity disorder	0.000429	0.000429	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	0.00021	0.00021	CbGpPWpGaD
